Hoth Therapeutics Inc. has announced that its board of directors has approved an employment agreement with Robb Knie, confirming his continued role as Chief Executive Officer and President. The agreement is set to commence on its effective date and will last for three years, with automatic one-year renewals. Robb Knie's employment may be terminated under specific conditions, including his death, disability, or by the company for cause, among others.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hoth Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-079915), on August 22, 2025, and is solely responsible for the information contained therein.